'Hepatitis c online' presentation slideshows

Sofosbuvir in HCV Genotype 2, 3 (PEG not an Option) POSITRON

Phase 3. Interferon Intolerant, Unwilling, or Ineligible. Sofosbuvir in HCV Genotype 2, 3 (PEG not an Option) POSITRON. *Note: Published in tandem with FUSION Trial (GT 2,3 and prior failure with PEG). Jacobson I, et al. N Engl J Med. 2013;368:1867-77.

246 views • 9 slides

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2 or 3 LONESTAR-2

Phase 2. Treatment Experienced. Sofosbuvir + Peginterferon + Ribavirin in Genotype 2 or 3 LONESTAR-2. Lawitz E, et al. 64th AASLD; Washington, DC. 2013. Abstract LB-4 . Sofosbuvir + PEG + RBV in Treatment-Experienced HCV GT 2 or 3 LONESTAR-2 Trial: Features.

279 views • 9 slides

Sofosbuvir, Ribavirin, GS - 0938 QUANTUM

390 views • 7 slides

Peginterferon alfa-2b + Ribavirin versus Interferon alfa-2b + Ribavirin

292 views • 7 slides

Boceprevir for Patients with Prior Failure to PEG + RIB PROVIDE

Phase 3. Treatment Experienced. Boceprevir for Patients with Prior Failure to PEG + RIB PROVIDE. Vierling JM, et al. J Hepatol . 2013;Dec 19 [ Epub ahead of print]. Boceprevir for Patients with Prior Failure to PEG + RIB PROVIDE Study: Features.

206 views • 6 slides

Peginterferon alfa - 2b + Ribavirin in Blacks & Non-Hispanic Whites

158 views • 6 slides

Peginterferon alfa-2b + Ribavirin for 12 or 24 Weeks in GT 2,3

183 views • 6 slides

Sofosbuvir + Ribavirin i n HCV GT 4 Egyptian Ancestry Trial

261 views • 6 slides

Sofosbuvir ELECTRON (Overview): 6 parts, 22 arms

153 views • 4 slides